The cobas® SARS-CoV-2 & Influenza A/B Test is a multiplex reverse transcription polymerase chain reaction (RT-PCR) assay intended for simultaneous qualitative detection and differentiation of SARS-CoV-2, influenza A virus, and/or influenza B virus in nasal or nasopharyngeal swab samples.

  • Provide accurate diagnosis of SARS-CoV-2 or Influenza A/B infection for proper patient management.
  • Offer reliable and affordable testing to reduce further virus spreading after close contact with infected individuals.
  • Leverage high-volume cobas® 6800/8800 Systems and broad menu to expand COVID-19 testing solutions.

cobas® SARS-CoV-2 & Influenza A/B is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .

Buy cobas® SARS-CoV-2 & Influenza A/B for Your WorkPlace

If your company or organisation is interested in rapid testing solutions, contact us today for help procuring cobas® SARS-CoV-2 & Influenza A/B for detecting SARS-CoV-2 or other rapid tests authorised by the Therapeutic Goods Administration (TGA)

If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for cobas® SARS-CoV-2 & Influenza A/B or other rapid tests approved by the TGA.

Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.

Kindly use the webchat to contact us. This is the most efficient way for us to track and respond to your query. Thank you for your understanding.

Proudly trusted by hundreds of organisations across the Globe

Stay up to date with Rapid Test & Trace Australia

Scroll to Top